|
BRPF3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9406032336633E-11 |
| Normal-vs-Stage2 |
8.1306000043746E-08 |
| Normal-vs-Stage3 |
2.16339999999926E-05 |
| Normal-vs-Stage4 |
1.595530E-04 |
| Stage1-vs-Stage2 |
1.947820E-01 |
| Stage1-vs-Stage3 |
1.456180E-02 |
| Stage1-vs-Stage4 |
1.334200E-01 |
| Stage2-vs-Stage3 |
2.449800E-01 |
| Stage2-vs-Stage4 |
6.607400E-01 |
| Stage3-vs-Stage4 |
6.014400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62436730732907E-12 |
| Normal-vs-AfricanAmerican |
1.8290002845589E-10 |
| Normal-vs-Asian |
1.680250E-03 |
| Caucasian-vs-AfricanAmerican |
7.266800E-01 |
| Caucasian-vs-Asian |
7.506600E-01 |
| AfricanAmerican-vs-Asian |
8.317000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.26799723235649E-11 |
| Normal-vs-Female |
2.40639730364478E-11 |
| Male-vs-Female |
7.454100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.09010586615932E-12 |
| Normal-vs-Extreme_Weight |
5.5969673340428E-12 |
| Normal-vs-Obese |
2.88480350718601E-11 |
| Normal-vs-Extreme_Obese |
3.37809999995109E-06 |
| Normal_Weight-vs-Extreme_Weight |
2.268000E-01 |
| Normal_Weight-vs-Obese |
1.672420E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.989800E-01 |
| Extreme_Weight-vs-Obese |
4.857700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.825600E-01 |
| Obese-vs-Extreme_Obese |
4.940600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.215110E-03 |
| Normal-vs-Age(41-60Yrs) |
4.77930028885964E-10 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
1.52677999999407E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.102600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.004900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.731600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.165800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.937200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.988600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.31970015313254E-11 |
| Normal-VS-Type2 PRCC |
2.70710009964148E-10 |
| Normal-VS-KIRP CIMP |
1.111770E-02 |
| Normal-VS-Unclassified PRCC |
1.5883999671118E-09 |
| Type1 PRCC-VS-Type2 PRCC |
3.545600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.083500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
4.482400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.923980E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.494200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.108300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.478694944268E-11 |
| Normal-vs-N1 |
7.864100E-03 |
| Normal-vs-N2 |
4.829200E-04 |
| N0-vs-N1 |
3.202600E-03 |
| N0-vs-N2 |
4.985000E-01 |
| N1-vs-N2 |
9.186100E-02 |
|
|
